Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Swathi PM
Eligibility
Inclusion criteria
Inclusion criteria: 1.Survivors of childhood cancer 2.Age = 5 years 3.Parents/guardians providing informed consent.
Exclusion criteria
Exclusion criteria: 1.Survivors with congenital Genito urinary malformations, Genetic syndromes, spinal defects, and neurologic disorder 2.Parents who refuse to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between chemotherapeutic agents and their cumulative dose with development of LUTDSTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| assessing the risk factors for LUTD in cancer survivor children on chemotherapyTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Vasudeva Bhat K
Kasturba Medical College Manipal
Outcome results
None listed